Małgorzata Chmielewska-Krzesińska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Małgorzata Chmielewska-Krzesińska has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
A. Jakimiuk
Department of Pathophysiology, Forensic Veterinary and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury, Oczapowskiego 13, 10-719 Olsztyn, Poland
2 shared publicationsK. Łosiewicz
2 shared publications- Krzysztof Wasowicz
Department of Pathophysiology, Forensic Veterinary Medicine and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, 10-719 Olsztyn, Poland
2 shared publications - Piotr Podlasz
Department of Pathophysiology, Forensic Veterinary and Administration, Faculty of Veterinary Medicine, University of Warmia and Mazury, Olsztyn, Poland
2 shared publications A. Raś
1 shared publication- Adam Kosiński
Division of Clinical Anatomy, Medical University of Gdańsk, Dębinki 1, 80-211 Gdańsk, Poland
1 shared publication
Latest Publications
- Open Access
- 25 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8598
Low-Dose Glyphosate Exposure Alters the Enteric Tachykinin System in the Porcine Small Intestine
Glyphosate is a widely used herbicide, yet its effects on the enteric nervous system (ENS) remain poorly understood. This study investigated the effects of low-dose glyphosate exposure on substance P (SP)-immunoreactive neurons and tachykinin receptor gene expression in the porcine small intestine. Fifteen juvenile pigs were assigned to three groups (n = 5 per group): a control group and two groups receiving oral glyphosate for 28 days at doses corresponding to the estimated maximum daily intake in Europe (0.05 mg/kg BW/day) and the acceptable daily intake (0.5 mg/kg BW/day). Double immunofluorescence was used to determine the percentage of SP-immunoreactive neurons in the myenteric (MP), outer submucosal (OSP), and inner submucosal (ISP) plexuses of the duodenum, jejunum, and ileum. The expression of TACR1, TACR2, and TACR3 was analysed by RT-qPCR. Glyphosate exposure increased the percentage of SP-immunoreactive neurons in all analysed intestinal segments and plexuses, with a clear dose-related pattern. TACR2 mRNA expression was significantly increased in the duodenum in both glyphosate-exposed groups but decreased in the ileum at the higher glyphosate dose. TACR3 mRNA expression was significantly decreased in the duodenum in both exposed groups and in the jejunum at the higher dose, whereas TACR1 expression remained unchanged. SOD activity was significantly increased in the duodenum and ileum of pigs exposed to the higher glyphosate dose, whereas no significant changes were observed in the jejunum. These findings demonstrate that low-dose glyphosate exposure is associated with region-specific alterations in selected components of the enteric tachykinin system, indicating a complex neurochemical response of the ENS to glyphosate.
- 25 September 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (19) , 8598
Open AccessLow-Dose Glyphosate Exposure Alters the Enteric Tachykinin System in the Porcine Small Intestine
Glyphosate is a widely used herbicide, yet its effects on the enteric nervous system (ENS) remain poorly understood. This study investigated the effects of low-dose glyphosate exposure on substance P (SP)-immunoreactive neurons and tachykinin receptor gene expression in the porcine small intestine. Fifteen juvenile pigs were assigned to three groups (n = 5 per group): a control group and two groups receiving oral glyphosate for 28 days at doses corresponding to the estimated maximum daily intake in Europe (0.05 mg/kg BW/day) and the acceptable daily intake (0.5 mg/kg BW/day). Double immunofluorescence was used to determine the percentage of SP-immunoreactive neurons in the myenteric (MP), outer submucosal (OSP), and inner submucosal (ISP) plexuses of the duodenum, jejunum, and ileum. The expression of TACR1, TACR2, and TACR3 was analysed by RT-qPCR. Glyphosate exposure increased the percentage of SP-immunoreactive neurons in all analysed intestinal segments and plexuses, with a clear dose-related pattern. TACR2 mRNA expression was significantly increased in the duodenum in both glyphosate-exposed groups but decreased in the ileum at the higher glyphosate dose. TACR3 mRNA expression was significantly decreased in the duodenum in both exposed groups and in the jejunum at the higher dose, whereas TACR1 expression remained unchanged. SOD activity was significantly increased in the duodenum and ileum of pigs exposed to the higher glyphosate dose, whereas no significant changes were observed in the jejunum. These findings demonstrate that low-dose glyphosate exposure is associated with region-specific alterations in selected components of the enteric tachykinin system, indicating a complex neurochemical response of the ENS to glyphosate.
- Open Access
- 12 May 2026
- Published by Elsevier in Research in Veterinary Science
- Vol. 209, 106250
Zebrafish xenografts reveal line-specific patterns of growth, survival, and metastases in canine mammary cell lines: CMT-U27, CMT-U131, and CMT-U229
- 12 May 2026
- Published by Elsevier in Research in Veterinary Science
- Vol. 209, 106250
Open AccessZebrafish xenografts reveal line-specific patterns of growth, survival, and metastases in canine mammary cell lines: CMT-U27, CMT-U131, and CMT-U229
- Open Access
Mapping the Kinase Inhibitor Landscape in Canine Mammary Carcinoma: Current Status and Future Opportunities
Background: Canine mammary carcinoma (CMC) is the most common malignant tumour in female dogs and, due to its similarities, is a valuable comparative model for human breast cancer. Kinase inhibitors have revolutionised the treatment of human breast cancer; their use in veterinary oncology remains marginal. Aim: This review summarises the current knowledge of kinase signalling pathways in CMC and assesses which kinase inhibitors approved for human use have potential in veterinary medicine. Methods: A systematic search of the PubMed database from 1985 to 2025 was performed, focusing on kinase-targeted therapies in both human and canine mammary carcinomas. Data were categorised according to molecular target, clinical approval status, and available preclinical or clinical veterinary evidence. Results: Key molecular pathways targeted by kinase inhibitors are conserved across species, supporting translational opportunities. In vitro studies demonstrate that palbociclib, alpelisib, everolimus, and lapatinib inhibit growth and signalling in CMC cell lines. Clinical trials have not been conducted. Conclusions: Approved kinase inhibitors for human use have untapped therapeutic potential in veterinary oncology. Translational research, including xenograft and organoid models, followed by clinical trials in dogs, is required. Gaining this knowledge could lead to targeted treatment for dogs while advancing comparative understanding of mammary cancer biology across species.
Open AccessMapping the Kinase Inhibitor Landscape in Canine Mammary Carcinoma: Current Status and Future Opportunities
Background: Canine mammary carcinoma (CMC) is the most common malignant tumour in female dogs and, due to its similarities, is a valuable comparative model for human breast cancer. Kinase inhibitors have revolutionised the treatment of human breast cancer; their use in veterinary oncology remains marginal. Aim: This review summarises the current knowledge of kinase signalling pathways in CMC and assesses which kinase inhibitors approved for human use have potential in veterinary medicine. Methods: A systematic search of the PubMed database from 1985 to 2025 was performed, focusing on kinase-targeted therapies in both human and canine mammary carcinomas. Data were categorised according to molecular target, clinical approval status, and available preclinical or clinical veterinary evidence. Results: Key molecular pathways targeted by kinase inhibitors are conserved across species, supporting translational opportunities. In vitro studies demonstrate that palbociclib, alpelisib, everolimus, and lapatinib inhibit growth and signalling in CMC cell lines. Clinical trials have not been conducted. Conclusions: Approved kinase inhibitors for human use have untapped therapeutic potential in veterinary oncology. Translational research, including xenograft and organoid models, followed by clinical trials in dogs, is required. Gaining this knowledge could lead to targeted treatment for dogs while advancing comparative understanding of mammary cancer biology across species.
- Open Access
- 16 February 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (4) , 2184
The Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progressive degeneration of upper and lower motor neurons that causes paralysis and muscle atrophy. The pathogenesis of the disease is still not elucidated. Receptor for Advanced Glycation End Product (RAGE) is a major component of the innate immune system and has implications in ALS pathogenesis. Multiple studies suggest the role of RAGE and its ligands in ALS. RAGE and its ligands are overexpressed in human and murine ALS motor neurons, astrocytes, and microglia. Here, we demonstrated the expression of RAGE and its ligands during the progression of the disease in the transgenic SOD1 G93A mouse lumbar spinal cord. We observed the highest expression of HMGB1 and S100b proteins at ALS onset. Our results highlight the potential role of RAGE and its ligands in ALS pathogenesis and suggest that some of the RAGE ligands might be used as biomarkers in early ALS diagnosis and potentially be useful in targeted therapeutic interventions at the early stage of this devastating disease.
- 16 February 2022
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (4) , 2184
Open AccessThe Involvement of RAGE and Its Ligands during Progression of ALS in SOD1 G93A Transgenic Mice
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by a progressive degeneration of upper and lower motor neurons that causes paralysis and muscle atrophy. The pathogenesis of the disease is still not elucidated. Receptor for Advanced Glycation End Product (RAGE) is a major component of the innate immune system and has implications in ALS pathogenesis. Multiple studies suggest the role of RAGE and its ligands in ALS. RAGE and its ligands are overexpressed in human and murine ALS motor neurons, astrocytes, and microglia. Here, we demonstrated the expression of RAGE and its ligands during the progression of the disease in the transgenic SOD1 G93A mouse lumbar spinal cord. We observed the highest expression of HMGB1 and S100b proteins at ALS onset. Our results highlight the potential role of RAGE and its ligands in ALS pathogenesis and suggest that some of the RAGE ligands might be used as biomarkers in early ALS diagnosis and potentially be useful in targeted therapeutic interventions at the early stage of this devastating disease.
- Open Access
The Anti-Tumoral Potential of Phosphonate Analog of Sulforaphane in Zebrafish Xenograft Model
Isothiocyanates (ITCs) show strong activity against numerous human tumors. Five structurally diverse ITCs were tested in vivo using the zebrafish embryos 6 and 48 h post-fertilization (hpf). The survival rate, hatching time, and gross morphological changes were assessed 24, 48, and 72 h after treatment with all compounds in various doses (1–10 µM). As a result, we selected a phosphonate analog of sulforaphane (P-ITC; 1–3 µM) as a non-toxic treatment for zebrafish embryos, both 6 and 48 hpf. Furthermore, the in vivo anti-cancerogenic studies with selected 3 µM P-ITC were performed using a set of cell lines derived from the brain (U87), cervical (HeLa), and breast (MDA-MB-231) tumors. For the experiment, cells were labeled using red fluorescence dye Dil (1,1′-Dioctadecyl-3,3,3′,3′-Tetramethylindocarbocyanine, 10 μg/mL) and injected into the hindbrain ventricle, yolk sac region and Cuvier duct of zebrafish embryos. The tumor size measurement after 48 h of treatment demonstrated the significant inhibition of cancer cell growth in all tested cases by P-ITC compared to the non-treated controls. Our studies provided evidence for P-ITC anti-cancerogenic properties with versatile activity against different cancer types. Additionally, P-ITC demonstrated the safety of use in the living organism at various stages of embryogenesis.
Open AccessThe Anti-Tumoral Potential of Phosphonate Analog of Sulforaphane in Zebrafish Xenograft Model
Isothiocyanates (ITCs) show strong activity against numerous human tumors. Five structurally diverse ITCs were tested in vivo using the zebrafish embryos 6 and 48 h post-fertilization (hpf). The survival rate, hatching time, and gross morphological changes were assessed 24, 48, and 72 h after treatment with all compounds in various doses (1–10 µM). As a result, we selected a phosphonate analog of sulforaphane (P-ITC; 1–3 µM) as a non-toxic treatment for zebrafish embryos, both 6 and 48 hpf. Furthermore, the in vivo anti-cancerogenic studies with selected 3 µM P-ITC were performed using a set of cell lines derived from the brain (U87), cervical (HeLa), and breast (MDA-MB-231) tumors. For the experiment, cells were labeled using red fluorescence dye Dil (1,1′-Dioctadecyl-3,3,3′,3′-Tetramethylindocarbocyanine, 10 μg/mL) and injected into the hindbrain ventricle, yolk sac region and Cuvier duct of zebrafish embryos. The tumor size measurement after 48 h of treatment demonstrated the significant inhibition of cancer cell growth in all tested cases by P-ITC compared to the non-treated controls. Our studies provided evidence for P-ITC anti-cancerogenic properties with versatile activity against different cancer types. Additionally, P-ITC demonstrated the safety of use in the living organism at various stages of embryogenesis.
- Open Access
- 6 October 2021
- Published by Walter de Gruyter GmbH in Journal of Veterinary Research
- Vol. 65 (4) , 513-517
Local and systemic influence of toxic levels of airborne ozone on the inflammatory response in rats
Introduction: Ozone is not harmful itself; however, it directly oxidises biomolecules and produces radical-dependent cytotoxicity. Exposure to ozone is by inhalation and therefore the lungs develop the main anti-inflammatory response, while ozone has an indirect impact on the other organs. This study investigated the local and systemic effects of the ozone-associated inflammatory response. Material and Methods: Three groups each of 5 Wistar Han rats aged 6 months were exposed for 2h to airborne ozone at 0.5 ppm and a fourth identical group were unexposed controls. Sacrifice was at 3h after exposure for control rats and one experimental group and at 24 h and 48 h for the others. Lung and liver samples were evaluated for changes in expression of transforming growth factor beta 1, anti-inflammatory interleukin 10, pro-inflammatory tumour necrosis factor alpha and interleukin 1 beta and two nuclear factor kappa-light-chain-enhancer of B cells subunit genes. Total RNA was isolated from the samples in spin columns and cDNA was synthesised in an RT-PCR. Expression levels were compared to those of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and analysed statistically. Results: All variables changed non-linearly over time comparing experimental groups to the control. Conspicuous expression changes in the subunit genes and cytokines were observed in both evaluated organs. Conclusion: Locally and systemically, inflammation responses to ozone inhalation include regulation of certain genes’ expression. The mechanisms are unalike in lungs and liver but ozone exerts a similar effect in both organs. A broader range of variables influential on ozone response should be studied in the future.
- 6 October 2021
- Published by Walter de Gruyter GmbH in Journal of Veterinary Research
- Vol. 65 (4) , 513-517
Open AccessLocal and systemic influence of toxic levels of airborne ozone on the inflammatory response in rats
Introduction: Ozone is not harmful itself; however, it directly oxidises biomolecules and produces radical-dependent cytotoxicity. Exposure to ozone is by inhalation and therefore the lungs develop the main anti-inflammatory response, while ozone has an indirect impact on the other organs. This study investigated the local and systemic effects of the ozone-associated inflammatory response. Material and Methods: Three groups each of 5 Wistar Han rats aged 6 months were exposed for 2h to airborne ozone at 0.5 ppm and a fourth identical group were unexposed controls. Sacrifice was at 3h after exposure for control rats and one experimental group and at 24 h and 48 h for the others. Lung and liver samples were evaluated for changes in expression of transforming growth factor beta 1, anti-inflammatory interleukin 10, pro-inflammatory tumour necrosis factor alpha and interleukin 1 beta and two nuclear factor kappa-light-chain-enhancer of B cells subunit genes. Total RNA was isolated from the samples in spin columns and cDNA was synthesised in an RT-PCR. Expression levels were compared to those of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and analysed statistically. Results: All variables changed non-linearly over time comparing experimental groups to the control. Conspicuous expression changes in the subunit genes and cytokines were observed in both evaluated organs. Conclusion: Locally and systemically, inflammation responses to ozone inhalation include regulation of certain genes’ expression. The mechanisms are unalike in lungs and liver but ozone exerts a similar effect in both organs. A broader range of variables influential on ozone response should be studied in the future.
- Open Access
- 9 March 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 359
Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models
Protamine sulfate (PS) is the only available option to reverse the anticoagulant activity of unfractionated heparin (UFH), however it can cause cardiovascular and respiratory complications. We explored the toxicity of PS and its complexes with UFH in zebrafish, rats, and mice. The involvement of nitric oxide (NO) in the above effects was investigated. Concentration–dependent lethality, morphological defects, and decrease in heart rate (HR) were observed in zebrafish larvae. PS affected HR, blood pressure, respiratory rate, peak exhaled CO2, and blood oxygen saturation in rats. We observed hypotension, increase of HR, perfusion of paw vessels, and enhanced respiratory disturbances with increases doses of PS. We found no effects of PS on human hERG channels or signs of heart damage in mice. The hypotension in rats and bradycardia in zebrafish were partially attenuated by the inhibitor of endothelial NO synthase. The disturbances in cardiovascular and respiratory parameters were reduced or delayed when PS was administered together with UFH. The cardiorespiratory toxicity of PS seems to be charge–dependent and involves enhanced release of NO. PS administered at appropriate doses and ratios with UFH should not cause permanent damage of heart tissue, although careful monitoring of cardiorespiratory parameters is necessary.
- 9 March 2021
- Published by MDPI AG in Pharmaceutics
- Vol. 13 (3) , 359
Open AccessCardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models
Protamine sulfate (PS) is the only available option to reverse the anticoagulant activity of unfractionated heparin (UFH), however it can cause cardiovascular and respiratory complications. We explored the toxicity of PS and its complexes with UFH in zebrafish, rats, and mice. The involvement of nitric oxide (NO) in the above effects was investigated. Concentration–dependent lethality, morphological defects, and decrease in heart rate (HR) were observed in zebrafish larvae. PS affected HR, blood pressure, respiratory rate, peak exhaled CO2, and blood oxygen saturation in rats. We observed hypotension, increase of HR, perfusion of paw vessels, and enhanced respiratory disturbances with increases doses of PS. We found no effects of PS on human hERG channels or signs of heart damage in mice. The hypotension in rats and bradycardia in zebrafish were partially attenuated by the inhibitor of endothelial NO synthase. The disturbances in cardiovascular and respiratory parameters were reduced or delayed when PS was administered together with UFH. The cardiorespiratory toxicity of PS seems to be charge–dependent and involves enhanced release of NO. PS administered at appropriate doses and ratios with UFH should not cause permanent damage of heart tissue, although careful monitoring of cardiorespiratory parameters is necessary.
- Open Access
- 19 August 2019
- Published by Polish Academy of Sciences Chancellery in Polish Journal of Veterinary Sciences
- Vol. 22 (3) , 523-529
Stability of αB-crystallin gene expression in canine mammary gland neoplasms. Should it be considered as circulating tumor cell genetic marker?
- 19 August 2019
- Published by Polish Academy of Sciences Chancellery in Polish Journal of Veterinary Sciences
- Vol. 22 (3) , 523-529
Open AccessStability of αB-crystallin gene expression in canine mammary gland neoplasms. Should it be considered as circulating tumor cell genetic marker?
- 1 January 2018
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 158, 139
Changes in the Expression of NF κ B and Nrf2 Genes in the Colon of Pigs Suffering From Swine Dysentery
- 1 January 2018
- Published by Elsevier in Journal of Comparative Pathology
- Vol. 158, 139
Changes in the Expression of NF κ B and Nrf2 Genes in the Colon of Pigs Suffering From Swine Dysentery
- 1 March 2013
- Published by Polish Academy of Sciences Chancellery in Polish Journal of Veterinary Sciences
- Vol. 16 (1) , 141-151
The application of circulating tumor cells detecting methods in veterinary oncology
Cancers are one of the most common diseases affecting dogs. Many of them develop spontaneously and their biology and histopathology shows many similarities to human cancers. What more, it is proved that there are much more analogies in molecular mechanisms of cancer development between these two species. Human oncology is seeking more and more efficient methods for an early disease detection which results directly in the extended life expectancy of patients affected. One of the most modern trends in the diagnosis of cancer is to detect circulating tumor cells (CTC) in the blood of patients. It is known that these cells are responsible for the formation of metastases in distant organs what results in the patient death. Moreover, it’s confirmed that CTC are already present in patients’ bloodstream in the early stages of tumor development. There is no doubt that mechanism of metastasis development in dogs is identical and thus the CTC are also present in their bloodstream. Despite the intense researches there is still no optimal method of isolating cancer cells from the blood where they occur extremely rarely. The purpose of this study is to analyze the implications of the detection methods of tumor cells in the blood in veterinary oncology.
- 1 March 2013
- Published by Polish Academy of Sciences Chancellery in Polish Journal of Veterinary Sciences
- Vol. 16 (1) , 141-151
The application of circulating tumor cells detecting methods in veterinary oncology
Cancers are one of the most common diseases affecting dogs. Many of them develop spontaneously and their biology and histopathology shows many similarities to human cancers. What more, it is proved that there are much more analogies in molecular mechanisms of cancer development between these two species. Human oncology is seeking more and more efficient methods for an early disease detection which results directly in the extended life expectancy of patients affected. One of the most modern trends in the diagnosis of cancer is to detect circulating tumor cells (CTC) in the blood of patients. It is known that these cells are responsible for the formation of metastases in distant organs what results in the patient death. Moreover, it’s confirmed that CTC are already present in patients’ bloodstream in the early stages of tumor development. There is no doubt that mechanism of metastasis development in dogs is identical and thus the CTC are also present in their bloodstream. Despite the intense researches there is still no optimal method of isolating cancer cells from the blood where they occur extremely rarely. The purpose of this study is to analyze the implications of the detection methods of tumor cells in the blood in veterinary oncology.